Supplementary materials: Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review.docx

<strong>Supplementary Figure 1</strong>. Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘PRISMA flow chart outlining the literature search’ </em> <br> <strong>Supplementary Table 1.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Detailed search strategy – mitral regurgitation studies’ </em> <br> <strong>Supplementary Table 2.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘Detailed search strategy – mitral stenosis studies’ </em> <br> <strong>Supplementary Table 3.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Detailed search strategy – tricuspid regurgitation studies’ </em> <br> <strong>Supplementary Table 4.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘Study characteristics of included studies on mitral regurgitation’ </em> <br> <strong>Supplementary Table 5.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <strong>‘</strong><em>Patients’ baseline and procedural characteristics of included studies on mitral regurgitation’</em> <br> <strong>Supplementary Table 6.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘Study characteristics of included studies on mitral stenosis’ </em> <br> <strong>Supplementary Table 7.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Patients’ baseline and procedural characteristics of included studies on mitral stenosis’ </em> <br> <strong>Supplementary Table 8.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘Study characteristics of included studies on tricuspid regurgitation’</em> <br> <strong>Supplementary Table 9.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Patients’ baseline and procedural characteristics of included studies on tricuspid regurgitation’</em> <br> <strong>Supplementary Table 10.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em>‘Baseline characteristics of all four valvular etiologies’</em> <em> </em> <strong>Supplementary Table 11.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Risk of bias in mitral regurgitation studies’ </em> <br> <strong>Supplementary Table 12.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review ‘<em>Risk of bias in mitral stenosis studies’</em> <br> <strong>Supplementary Table 13.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review <em><strong>‘</strong></em><em>Risk of bias in tricuspid regurgitation studies’</em> <br> <strong>Supplementary File 1.</strong> Evaluating the Effect of Multivalvular Disease on Mortality After TAVR for Aortic Stenosis: A meta-analysis and systematic review